Our systems have detected that you are using a computer with an IP address located in the USA.
If you are currently not located in the USA, please click “Continue” in order to access our Website.

Local restrictions - provision of cross-border services

Swissquote Bank Ltd (“Swissquote”) is a bank licensed in Switzerland under the supervision of the Swiss Financial Market Supervisory Authority (FINMA). Swissquote is not authorized as a bank or broker by any US authority (such as the CFTC or SEC) neither is it authorized to disseminate offering and solicitation materials for offshore sales of securities and investment services, to make financial promotion or conduct investment or banking activity in the USA whatsoever.

This website may however contain information about services and products that may be considered by US authorities as an invitation or inducement to engage in investment activity having an effect in the USA.

By clicking “Continue”, you confirm that you have read and understood this legal information and that you access the website on your own initiative and without any solicitation from Swissquote.



Aquafarming is booming

By Julie Zaugg
19.10.2017 - 15:30

“Manufacturers see the maritime industry as risky, but appealing”

By Ludovic Chappex
11.10.2017 - 10:45

Dossier Pharma

21.09.2017 - 10:00

“Airbus and Boeing need not worry”

By Stanislas Cavalier
07.09.2017 - 07:45

In the shadows of the pharma industry, clinical trial prosper

By Julie Zaugg
01.09.2017 - 07:30

“Disruptive companies will break into the market”

By Ludovic Chappex
01.09.2017 - 07:15

Pharma - Cutting-edge Swiss companies

By Ludovic Chappex
01.09.2017 - 07:00

When pharma outsources production

By Marie Maurisse
01.09.2017 - 07:00

21st century medicine

By Julie Zaugg
30.08.2017 - 11:15

5 Swiss firms in the forefront

By Ludovic Chappex and Julie Zaugg
30.08.2017 - 10:00
Live chat